Latest Articles

Publication Date
GSK enters Indian oncology market with gynaecological cancer drugs - MSN

GSK enters Indian oncology market with gynaecological cancer drugs MSN

Published: Aug. 28, 2025, 8:16 a.m.
Metastatic Carcinomas at the Episiotomy Site: A Systematic Literature Review.

Background/Objectives: Rarely, primary (PriCs) or metastatic (metECs) carcinomas occur in the episiotomy site. Methods: A systematic literature review of metECs was carried out. We reviewed the PRISMA guidelines and the …

Published: Aug. 27, 2025, midnight
New Perspectives on the Use of Resveratrol in the Treatment of Metabolic and Estrogen-Dependent Conditions Through Hormonal Modulation and Anti-Inflammatory Effects.

Estrogen-dependent conditions, such as endometriosis, adenomyosis, lipedema, polycystic ovary syndrome, and breast cancer, are intimately involved with hormonal changes related to estrogen and their receptors. These conditions can be expressed …

Published: Aug. 27, 2025, midnight
Rina-S Earns FDA Breakthrough Therapy Designation in Endometrial Cancer - CancerNetwork

Rina-S Earns FDA Breakthrough Therapy Designation in Endometrial Cancer CancerNetwork

Published: Aug. 26, 2025, 10:07 p.m.
Genmab's Rina-S: A Game-Changer in Endometrial Cancer and a Catalyst for Shareholder Value - AInvest

Genmab's Rina-S: A Game-Changer in Endometrial Cancer and a Catalyst for Shareholder Value AInvest

Published: Aug. 26, 2025, 7:31 p.m.
FDA Breakthrough Therapy Granted for Novel ADC in Endometrial Cancer - Targeted Oncology

FDA Breakthrough Therapy Granted for Novel ADC in Endometrial Cancer Targeted Oncology

Published: Aug. 26, 2025, 6:30 p.m.
Rina-S Given Breakthrough Therapy Designation in Endometrial Cancer - Oncology Nursing News

Rina-S Given Breakthrough Therapy Designation in Endometrial Cancer Oncology Nursing News

Published: Aug. 26, 2025, 6:04 p.m.
Genmab's Rina-S: A Breakthrough in Endometrial Cancer and a Catalyst for Shareholder Value - AInvest

Genmab's Rina-S: A Breakthrough in Endometrial Cancer and a Catalyst for Shareholder Value AInvest

Published: Aug. 26, 2025, 5:39 p.m.
Rina-S Earns Breakthrough Designation in Advanced Endometrial Cancer - Curetoday

Rina-S Earns Breakthrough Designation in Advanced Endometrial Cancer Curetoday

Published: Aug. 26, 2025, 4:06 p.m.
Olaparib Maintenance in Advanced Endometrial Cancer Trial - BIOENGINEER.ORG

Olaparib Maintenance in Advanced Endometrial Cancer Trial BIOENGINEER.ORG

Published: Aug. 26, 2025, 3:07 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!